The 2023 American Society of Clinical Oncology (ASCO) conference in Chicago brought together more than 40,000 people engaged in all aspects of cancer research, care, and advocacy.
Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.
NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease.
Researchers are working on a first-of-its-kind vaccine to prevent triple-negative breast cancer (TNBC) from developing.
Mary J. Blige has spent her career using music to express her emotions. Raw and authentic to the core, the nine-time Grammy winner is now using her formidable voice to galvanize women with their most powerful asset – their health.
Professor Geoff Lindeman discusses genetics and breast cancer, as well as world first research in the BRCA-P clinical trial.
ERX-41, discovered by UT Southwestern scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors.
“Smarter screening” and a better understanding of the breast cancers women of color are more likely to develop are all crucial to helping these patients survive this disease at the same rates as their White counterparts.
Scientists at Case Western Reserve University have used artificial intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment—and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer.
Most of us have heard about the BRCA1 and BRCA2 genes...but what about the PALB2 gene, which stands for Partner And Locator of BRCA2?
- ← Previous
- 1
- 2 (current)
- 3
- 4
- Next →